# Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies

> **NCT02447926** · NA · TERMINATED · sponsor: **Northwestern University** · enrollment: 1 (actual)

## Conditions studied

- End Stage Liver Disease

## Interventions

- **PROCEDURE:** Leukapheresis

## Key facts

- **NCT ID:** NCT02447926
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Successful proof of concept study after 1 subject.
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447926, "Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02447926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*